Suppr超能文献

真正得到控制的耐药性高血压患者不存在不良心脏重构。

Adverse cardiac remodeling is absent in patients with true controlled resistant hypertension.

机构信息

Vascular Biology and Hypertension Program, University of Alabama at Birmingham, Birmingham, USA.

Jordan University of Science and Technology, Irbid, Jordan.

出版信息

J Clin Hypertens (Greenwich). 2023 May;25(5):416-425. doi: 10.1111/jch.14625. Epub 2023 Apr 3.

Abstract

Resistant hypertension (RHTN), defined as blood pressure (BP) that is uncontrolled with ≥3 medications, including a long-acting thiazide diuretic, also includes a subset with BP that is controlled with ≥4 medications, so-called controlled RHTN. This resistance is attributed to intravascular volume excess. Patients with RHTN overall have a higher prevalence of left ventricular hypertrophy (LVH) and diastolic dysfunction compared to patients with non-RHTN. We tested the hypothesis that patients with controlled RHTN due to the intravascular volume excess have higher left ventricular mass index (LVMI), higher prevalence of LVH, larger intracardiac volumes, and more diastolic dysfunction compared to patients with controlled non-resistant hypertension (CHTN), defined as BP controlled with ≤3 anti-hypertensive medications. Patients with controlled RHTN (n = 69) or CHTN (n = 63) who were treated at the University of Alabama at Birmingham were offered enrollment and underwent cardiac magnetic resonance imaging. Diastolic function was assessed by peak filling rate, time needed in diastole to recover 80% of stroke volume, E:A ratios and left atrial volume. LVMI was higher in patients with controlled RHTN (64.4 ± 22.5 vs 56.9 ± 11.5; P = .017). Intracardiac volumes were similar in both groups. Diastolic function parameters were not significantly different between groups. There were no significant differences in age, gender, race, body mass index, dyslipidemia between the two groups. The findings show that patients with controlled RHTN have higher LVMI, but comparable diastolic function to those of patients with CHTN.

摘要

抗药性高血压(RHTN)定义为血压(BP)不受控制,即使使用≥3 种药物治疗,包括一种长效噻嗪类利尿剂,还包括一部分患者需要使用≥4 种药物来控制血压,即所谓的控制性 RHTN。这种耐药性归因于血管内容量过多。与非 RHTN 患者相比,总体上 RHTN 患者左心室肥厚(LVH)和舒张功能障碍的发生率更高。我们假设,由于血管内容量过多导致的控制性 RHTN 患者的左心室质量指数(LVMI)更高,LVH 的患病率更高,心内容积更大,舒张功能障碍更严重,与血压控制在≤3 种抗高血压药物的控制性非耐药性高血压(CHTN)患者相比。在阿拉巴马大学伯明翰分校接受治疗的控制性 RHTN(n=69)或 CHTN(n=63)患者被提供入组机会并接受了心脏磁共振成像检查。舒张功能通过峰值充盈率、舒张期恢复 80%射血量所需的时间、E:A 比值和左心房容积来评估。与 CHTN 患者相比,控制性 RHTN 患者的 LVMI 更高(64.4±22.5 vs 56.9±11.5;P=0.017)。两组的心脏内容积相似。两组间舒张功能参数无显著差异。两组间在年龄、性别、种族、体重指数、血脂异常等方面无显著差异。这些发现表明,与 CHTN 患者相比,控制性 RHTN 患者的 LVMI 更高,但舒张功能相似。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/90fe/10184488/4dd0926c58fb/JCH-25-416-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验